Barclays »

Lantern Pharma shares owned by Barclays

Quarter-by-quarter ownership of Lantern Pharma (LTRN) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Lantern Pharma

Tip: Access up to 7 years of quarterly data

All positions including Lantern Pharma held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lantern Pharma by Barclays

Quarter filed Position value Share count Share price at filing
2026-06-30 $25 6 4.17

More positions owned by Barclays

STATE STR SPDR S&ampP 500 ETF T Fund (SPY)
Ishares Tr Opt Call Option (EEM)
Microsoft Corp Opt Call Option (MSFT)
Invesco Qqq Tr Fund (QQQ)
Ishares Tr Fund (IWM)
Nvidia Corporation Opt Call Option (NVDA)
Micron Technology (MU)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon Opt Put Option (AMZN)
Vaneck Etf Trust Opt Put Option (SMH)
Tesla Motors (TSLA)
Advanced Micro Devices Opt Put Option (AMD)
Broadcom Opt Put Option (AVGO)
Ishares Tr Opt Call Option (HYG)

View all positions for Barclays

Top funds holding Lantern Pharma

Empery Asset Management
CM Management
Vanguard Capital Management
Renaissance Technologies
BIOS Capital Management
Geode Capital Management
Vanguard Fiduciary Trust
Citadel Advisors
Westside Investment Management
Quadrature Capital
Goss Wealth Management
Horizon Kinetics Asset Management
Davenport & Co
State Street Corporation
BlackRock

View all funds holding Lantern Pharma